Follow me on Twitter @madaznfootballr and Profit.ly www.profit.ly/users/madaz
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Bang Bang! People are missing out on this $PVCT
Added more $PVCT i have 40,000 shares now.
Holding about 17K shares from 3.09605 avg. Looking for 4 bucks tomorrow on the uplist. $PVCT
Should gap up and run to and past .60 tomorrow. Holding 20,000 shares at .50 average for gap and runner. $GRNH
3.17 bid now. It's gonna gap up and run $FNMA
Good ol' ATM Machine $FNMA back again. In 40,000 shares at 3.02, looking for 3.50 tomorrow. $$$$$$$$$$
They keep screwing shorts with these fakeout dips. It drops 2 cents, shorts get in and rip it right back to highs. $TGLO
$TGRO Big pump right now from the guys that did $PGLO. $1 target on this one easy!
$TGRO Big pump right now from the guys that did $PGLO. $1 target on this one easy!
$TGRO Big pump right now from the guys that did $PGLO. $1 target on this one easy!
Ripped though .60 like it was nothing wow
Looking solid. $TGRO
Dips being bought all day. Gonna stick around for this one. has a pretty good chance to go towards $1 seeing how the first day volume on it is a lot higher than $PGLO 's. $TGRO
In .44 10K shares for a swing. Let's see if stocktips is legit and can push this to $1.
Easy money today on $AAMRQ. Thanks for a gift of a dip. In 5.42, out 5.75, then Short 6.45, Covered 6.25.
FNMA indeed never disappoints. Should be in play as long as the volume is still > 75M.
$FNMA never fails to pay out. Got in 1.90 got out 2.10 62,000 shares. +$12,400. +$14,445 total gains today. t.co/mgoRCpklcR
That's not necessarily true, it could just means a bunch of shorts will try to short it, doesn't mean they will succeed. All Brighton had to do was support the bid and absorb the shorts and squeeze them. Instead they fell asleep on the job and the flood gates opened.
$NNRX 60 cent linear move last week. Brighton picks tend to go parabolic after emails hit (see $TALK $GNIN charts). $NNRX is going to go up at least $1 this week to around $2.50 area, easy.
Previous Brighton play $TALK gapped up 9 cents and ran another 11 cents after emails hit. High probability gap and runner on Monday $NNRX
$NNRX CONFIRMED - BRIGHTON EMAILS OUT
Our New Pick is NNRX
Valued Members,
Are you ready for another strong performer?
Our selection for this quarter is Nutranomics, Inc. (NNRX), a company reconciling the gap between science and nature, while driving revenue growth in the process. Unlike so many biotech plays, NNRX is already reporting revenue. In fact, NNRX surpassed $5.6M in sales over the past two years, has products on shelves and is making headway into large distribution networks.
We are proud to be introducing this company to our valued subscribers below a $70M valuation, especially when we look to the upside available.
A Healthy Play: NNRX
One of the best ways to familiarize yourself is to watch one of the many lectures, interviews and presentations with Nutranomics' current CEO, Dr. Tracy Gibbs.
In one presentation, Dr. Gibbs gave a profound definition of health, in contrast to what so often comes to mind. (Paraphrased:) "Health is not simply the absence of disease, but a state of well-being. Health is being able to come home from a full day's work and still have an abundance of vitality, the energy to give your children the attention they deserve, take time for yourself, your hobbies and treat your significant other. Health is being able to put in a full 18 hours and still be able to sleep well at night."
Nutranomics is about creating products so everyone can be healthy. Everyone should be able to spend time with their friends and family, enjoy an abundance of life – and not be subject to premature disease or health problems.
Closing the Gap: Nature's Science
Nutranomics is natural health without the quackery. All of its facilities are cGMP Compliant and FDA Approved. Nutranomics provides dietary supplements and the company does not make unsubstantiated claims. The products offered are not intended to diagnose, treat, cure, or prevent any disease. Rather, the products are offered to help promote a healthy lifestyle. As it turns out, consumers (and the FDA) appreciate this honesty and the revenue numbers speak for themselves.
Instead of pseudoscience, Nutranomics focuses on evidence and clinical trials.
In a message to its base last Friday, Nutranomics outlined its focus on growing the company and building upon the foundation established over the last seventeen years. "We believe that we are on the verge of an exciting period growth and development," commented Tracy Gibbs, Nutranomics' CEO. Given its tremendous success in the public arena thus far, we tend to agree with this assessment.
Predicting Going Forward
We speculate that Nutranomics will look to leverage its growing valuation to shore up its cash position and potentially focus on pursuing Phase I, II and III clinical trials for select products in its portfolio (currently over 850 nutritional food and supplement formulas including already patented AES® technology). We believe this may have been a driving factor toward Nutranomics push to go public and hint at a much larger picture ahead.
We must disclaim that this is purely speculative and conjecture based on several assumptions – there is no way to conclusively determine the true intention or inner workings of the company at this stage.
However, we are comfortable with the current company's valuation and historical performance and see tremendous upside regardless of the clinical trial route. Further, we have historically observed a pattern of companies going public to take on larger markets and we believe this makes a realistic case for Nutranomics announcing a large undertaking and significant catalyst event shortly.
Conclusion
All in all, we believe we have found the next top performer as it begins to take off. NNRX's performance to date demonstrates growing interest, with Friday closing up 6.72% at $1.43. This next week could present an ideal entry opportunity for our subscriber base below the $2.00 mark. At its current rate, momentum and technicals point to a much more expensive November for NNRX.
Remember – all of the above information is just that, information. It represents our opinion only. Please use this as a starting point for your own due diligence. Come to your own conclusions about NNRX and where you believe it will go. For us, we believe the facts will speak for themselves.
Sincerely,
Newsletter Team
Research Department
Investors Alliance
There are important disclosures you should know about.
Read our Legal Disclaimer and Compliance Disclosures.
We received your permission to send these emails.
No longer interested? 1-Click Unsubscribe.
Investors Alliance
Dowdeswell Street, Nassau, Bahamas, CB-13878
Any wall that shows up gets taken out eventually. Unreal $NNRX
1.40s up bro $NNRX
Same pattern everyday, 3-4 cent drop and pop right back to highs in 1 minute.
1.37 up on $NNRX wow!
$NNRX more highs
Still going 1.30 up $NNRX !!!
Another close near the high of day, 3 days in a row. That's the epitome of a strong bullish stock folks! $NNRX
$NNRX nHOD again. What a beast of a stock. up $5,350 now!
All dips are being bought instantly. Been the case everyday so far. Pretty bullish to me. $NNRX
1.21 on bid now $NNRX
Here's a dip for people to load! $NNRX
1.20s tomorrow $NNRX already up $3,350.
It dipped to 1.00 for a split second and ripped right back to 1.05. Promoters are actively suppporting the bid. $NNRX
$NNRX $2-$3 target easy.
Up nice on $NNRX already
$1.00 on Bid now $NNRX